Assessment of human influenza pandemic scenarios in Europe
Napoli, C., Fabiani, M., Rizzo, C., Barral, M., Oxford, J., Cohen, J.M., Niddam, L., Goryński, P., Pistol, A., Lionis, C., Bri, S., Nicoll, A., Penttinen, P., Gauci, C., Bounekkar, A., Bonnevay, S., Beresniak, A.
Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
Targeted testing for viral hepatitis: Europe’s persistent public health challenge
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.
Guide to public health measures to reduce the impact of influenza pandemics in Europe – ‘The ECDC Menu’
This document presents a menu of possible public measures to be taken during influenza pandemics, giving public health and scientific information on what is known or can be said about their likely effectiveness, costs (direct and indirect), acceptability, public expectations and other more practical considerations. The ‘ECDC Menu’ aims to help EU Member States and institutions, individually or collectively, decide which measures they will apply.
1st Eastern Partnership Ministerial Conference on Tuberculosis and Multi-Drug Resistance Tuberculosis
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.
Interim ECDC public health guidance on case and contact management for the new influenza A(H1N1) virus infection
ECDC intends to produce a series of interim guidance documents on suggested procedures to be put in place in order to reduce the risk of transmission of the new influenza A(H1N1) virus. This guidance only applies to a situation when there are relatively few persons under investigation, and will be revised if there seems to be a wider spread.
Are statins protective in patients with severe respiratory infections? Two new studies from EuropeArchived
In recent years there have been a series of arguments and findings suggesting that Statins (HMG-CoA reductase inhibitors) which used widely to lower cholesterol levels may also be important in reducing the risk associated with severe infective conditions.
Chronological overview of the 2009/2010 H1N1 influenza pandemic and the response of the Centre for Infectious Disease Control (RIVM)Archived
The Centre for Infectious Disease Control (CIb) of the Dutch National Institute for Public Health and the Environment (RIVM) has compiled a chronological overview of that country’s response to the 2009 influenza A(H1N1) pandemic.